Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fleischhacker

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Expert Review of Respiratory Medicine|August 23, 2013
The role of DNA methylation as biomarkers in the clinical management of lung cancerMichael Fleischhacker, Dimo Dietrich, Volker Liebenberg, et al.
Plos One|February 13, 2015
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patientsBernd Schmidt, Julia Beyer, Dimo Dietrich, et al.
Annals of the New York Academy of Sciences|July 15, 2004
Detection of cell-free DNA in bronchial lavage fluid supernatants of patients with lung cancerTim Carstensen, Bernd Schmidt, Eileen Engel, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection?Bernd Schmidt, Eileen Engel, Tim Carstensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 5, 2017
Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patientsBernd Schmidt, Dana Reinicke, Iris Reindl, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2011
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasmaChristoph Kneip, Bernd Schmidt, Anke Seegebarth, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2011
Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technologyTonio Oumeraci, Bernd Schmidt, Thomas Wolf, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 25, 2011
Methods for isolation of cell-free plasma DNA strongly affect DNA yieldMichael Fleischhacker, Bernd Schmidt, Sabine Weickmann, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Cell-Free Methylated <i>PTGER4</i> and <i>SHOX2</i> Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC PatientsMichael Fleischhacker, Erkan Arslan, Dana Reinicke, et al.
Biotechniques|October 27, 2009
A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cyclingChristoph Kneip, Bernd Schmidt, Michael Fleischhacker, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Expert Review of Respiratory Medicine|August 23, 2013
The role of DNA methylation as biomarkers in the clinical management of lung cancerMichael Fleischhacker, Dimo Dietrich, Volker Liebenberg, et al.
Plos One|February 13, 2015
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patientsBernd Schmidt, Julia Beyer, Dimo Dietrich, et al.
Annals of the New York Academy of Sciences|July 15, 2004
Detection of cell-free DNA in bronchial lavage fluid supernatants of patients with lung cancerTim Carstensen, Bernd Schmidt, Eileen Engel, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection?Bernd Schmidt, Eileen Engel, Tim Carstensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 5, 2017
Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patientsBernd Schmidt, Dana Reinicke, Iris Reindl, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2011
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasmaChristoph Kneip, Bernd Schmidt, Anke Seegebarth, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2011
Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technologyTonio Oumeraci, Bernd Schmidt, Thomas Wolf, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 25, 2011
Methods for isolation of cell-free plasma DNA strongly affect DNA yieldMichael Fleischhacker, Bernd Schmidt, Sabine Weickmann, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Cell-Free Methylated <i>PTGER4</i> and <i>SHOX2</i> Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC PatientsMichael Fleischhacker, Erkan Arslan, Dana Reinicke, et al.
Biotechniques|October 27, 2009
A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cyclingChristoph Kneip, Bernd Schmidt, Michael Fleischhacker, et al.
Pageof 3